2nd Annual MaxPotent Pharma Summit 2026

2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs).

This year’s edition builds on the strong foundation of our inaugural summit, with an expanded agenda designed to address the critical challenges and opportunities across the HPAPI value chain. Over two intensive days, the conference will highlight the latest developments in EU and global regulatory frameworks, emerging containment and isolation technologies, and state-of-the-art automation and process engineering that are transforming manufacturing practices.

Delegates will gain actionable insights from real-world case studies, panel discussions, and technical presentations covering occupational health and safety standards, scaling-up strategies, risk-based exposure assessments, and supply chain resilience. Particular emphasis will be placed on partnership models with CDMOs/CMOs, sustainability in high-potency operations, and the integration of digital tools and data-driven decision-making in pharma manufacturing.

By convening experts from across the globe, the MaxPotent Pharma Summit fosters meaningful dialogue, collaborative learning, and knowledge exchange. Whether you are a pharmaceutical manufacturer, regulatory specialist, technology innovator, or solution provider, this event offers a unique opportunity to connect with peers, strengthen professional networks, and explore pioneering solutions that are shaping the next generation of high-potency drug development.